Jeff Yass’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,482
Closed -$158K 13734
2023
Q3
$158K Buy
15,482
+1,099
+8% +$8.37K ﹤0.01% 10497
2023
Q2
$67.6K Sell
14,383
-3,361
-19% -$15.4K ﹤0.01% 11202
2023
Q1
$82K Buy
+17,744
New +$78.1K ﹤0.01% 11422
2022
Q4
Sell
-10,646
Closed -$50K 14167
2022
Q3
$50K Sell
10,646
-7,848
-42% -$39.4K ﹤0.01% 12209
2022
Q2
$90K Buy
+18,494
New +$112K ﹤0.01% 11568

Jeff Yass's THRN Position: Q4 2023 in Review

Jeff Yass sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 15,482 shares — an estimated $158K sold.

Jeff Yass first reported a position in THRN in Q2 2022 and held it in 5 quarters. The position peaked at $158K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Jeff Yass reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Jeff Yass sold 15,482 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $158K.
  • Jeff Yass first reported a position in Thorne Healthtech, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Jeff Yass's Thorne Healthtech, Inc. Common Stock position peaked at $158K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.